Halozyme Therapeutics, Inc. (Nasdaq: HALO) has entered into a worldwide Collaboration and License Agreement with Pfizer Inc. (NYSE: PFE) for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE